Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Aug 31, 2025 | (Q1)May 31, 2025 | (FY)Feb 28, 2025 | (Q4)Feb 28, 2025 | (Q3)Nov 30, 2024 | (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | -13.55%21.53K | -14.77%21.53K | -58.30%95.83K | -44.20%20.77K | -63.28%24.9K | -59.98%24.9K | -59.61%25.26K | -8.09%229.81K | -40.48%37.22K | 8.50%67.82K |
| Gross profit | 13.55%-21.53K | 14.77%-21.53K | 58.30%-95.83K | 44.20%-20.77K | 63.28%-24.9K | 59.98%-24.9K | 59.61%-25.26K | 8.09%-229.81K | 40.48%-37.22K | -8.50%-67.82K |
| Operating expense | 181.27%814.28K | -30.27%298.97K | -15.66%2.05M | 48.56%694.77K | 29.39%633.68K | -63.70%289.5K | -36.19%428.78K | -22.09%2.43M | -26.58%467.67K | -31.05%489.74K |
| Selling and administrative expenses | -5.87%153.12K | -10.69%138.02K | -1.05%633.34K | -0.43%159.57K | 0.43%156.56K | -8.23%162.67K | 5.37%154.54K | -21.80%640.06K | -23.99%160.26K | -12.26%155.89K |
| -Selling and marketing expense | 61.22%57.4K | 16.67%35K | 5.28%128.44K | -57.13%30.44K | 116.00%32.4K | 11.26%35.6K | -1.82%30K | -64.33%122K | 17.64%71K | -79.96%15K |
| -General and administrative expense | -24.67%95.72K | -17.28%103.02K | -2.54%504.9K | 44.67%129.13K | -11.87%124.16K | -12.52%127.07K | 7.27%124.54K | 8.72%518.06K | -40.68%89.26K | 37.02%140.89K |
| Other operating expenses | 421.30%661.16K | -41.31%160.95K | -20.90%1.41M | 74.09%535.2K | 42.92%477.12K | -79.55%126.83K | -47.80%274.23K | -22.20%1.79M | -27.86%307.42K | -37.32%333.85K |
| Operating profit | -165.84%-835.81K | 29.41%-320.49K | 19.35%-2.14M | -41.72%-715.53K | -18.12%-658.58K | 63.43%-314.4K | 38.19%-454.03K | 21.05%-2.66M | 27.82%-504.89K | 27.85%-557.55K |
| Net non-operating interest income (expenses) | -114.82%-145.81K | -140.19%-103.54K | -264.64%-327.66K | -127.43%-111.45K | -638.72%-171.29K | -382.75%-67.88K | -1,094.76%-43.11K | -359.96%-89.86K | -3,432.95%-49K | -363.02%-23.19K |
| Non-operating interest expense | 114.85%145.79K | 142.01%103.49K | 265.92%327.26K | 127.45%111.41K | 646.14%171.28K | 386.32%67.86K | 1,107.37%42.77K | 371.40%89.43K | 2,002.32%48.98K | 379.03%22.96K |
| Total other finance cost | 0.00%19 | -86.84%45 | -6.37%397 | 72.22%31 | -92.27%18 | -82.24%19 | 418.18%342 | -24.82%424 | 101.91%18 | 7.87%233 |
| Other net income (expenses) | -73.47%14.25K | -7.71%13.12K | 69.48%94.73K | -10.56%13.45K | 197.75%53.57K | 408.86%53.7K | 15.41%14.21K | -49.58%55.89K | -52.32%15.04K | 10.50%17.99K |
| Gain on sale of security | --747 | -154.23%-385 | 103.42%695 | 94.24%-52 | 101.76%37 | ---- | 109.12%710 | 85.60%-20.34K | -107.75%-902 | 34.47%-2.11K |
| Special income (charges) | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --238 | ---- | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---238 | ---- | ---- |
| Other non-operating income (expenses) | -74.86%13.5K | 0.00%13.5K | 23.73%94.03K | -14.01%13.5K | 166.34%53.53K | 167.16%53.7K | -32.84%13.5K | -69.85%76K | -21.11%15.7K | 3.08%20.1K |
| Income before tax | -194.41%-967.37K | 14.91%-410.92K | 11.71%-2.38M | -50.97%-813.53K | -37.95%-776.31K | 61.93%-328.58K | 33.46%-482.93K | 17.81%-2.69M | 19.50%-538.86K | 26.10%-562.75K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -194.41%-967.37K | 14.91%-410.92K | 11.71%-2.38M | -50.97%-813.53K | -37.95%-776.31K | 61.93%-328.58K | 33.46%-482.93K | 17.81%-2.69M | 19.50%-538.86K | 26.10%-562.75K |
| Net income continuous operations | -194.41%-967.37K | 14.91%-410.92K | 11.71%-2.38M | -50.97%-813.53K | -37.95%-776.31K | 61.93%-328.58K | 33.46%-482.93K | 17.81%-2.69M | 19.50%-538.86K | 26.10%-562.75K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -194.41%-967.37K | 14.91%-410.92K | 11.71%-2.38M | -50.97%-813.53K | -37.95%-776.31K | 61.93%-328.58K | 33.46%-482.93K | 17.81%-2.69M | 19.50%-538.86K | 26.10%-562.75K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -194.41%-967.37K | 14.91%-410.92K | 11.71%-2.38M | -50.97%-813.53K | -37.95%-776.31K | 61.93%-328.58K | 33.46%-482.93K | 17.81%-2.69M | 19.50%-538.86K | 26.10%-562.75K |
| Diluted earnings per share | -100.00%-0.02 | 0.00%-0.01 | 20.00%-0.04 | 0.00%-0.01 | 0.00%-0.01 | 50.00%-0.01 | 50.00%-0.01 | 44.44%-0.05 | 0.00%-0.01 | 50.00%-0.01 |
| Basic earnings per share | -100.00%-0.02 | 0.00%-0.01 | 20.00%-0.04 | 0.00%-0.01 | 0.00%-0.01 | 50.00%-0.01 | 50.00%-0.01 | 44.44%-0.05 | 0.00%-0.01 | 50.00%-0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.